Comment by
jeffm34 on Apr 15, 2022 1:32am
An additional location has also been added. Mary Crowley cancer research in Dallas Texas
Comment by
qwerty22 on Apr 15, 2022 9:39am
You are right about the ocular addition but when you look at the history of changes it shows they did an extensive rewrite on the whole inclusion/exclusion section and other parts. https://clinicaltrials.gov/ct2/history/NCT04706962?A=4&B=5&C=Side-by-Side#StudyPageTop
Comment by
jfm1330 on Apr 15, 2022 12:12pm
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677113/
Comment by
qwerty22 on Apr 15, 2022 12:29pm
The thing I think I heard Christian sorta mumbled at the financial year report in Feb was that the 3 AEs in the 420 group which were on top of the neutropenia DLT were all the type of side effects seen with docetaxel. It's so vague and they've used up all their trust points with me so who knows exactly what that means. I guess it all comes down to manageability.
Comment by
qwerty22 on Apr 16, 2022 12:33pm
CRO - contract research organization